Agios Pharmaceuticals (NASDAQ:AGIO) used its presentation at the 44th Annual J.P. Morgan Healthcare Conference to outline its ...
MedPage Today on MSN
Autoimmune Anemia Is the Latest Condition Found Responsive to CAR-T Therapy
Eleven patients with refractory autoimmune hemolytic anemia (AIHA) were all brought into drug-free remission with CAR T-cell ...
According to DelveInsight’s latest analysis, Nipocalimab is expected to capture meaningful market share across both prevalent ...
No Name” brand beef burgers are under recall in Canada because tests have shown contamination with E.coli. The frozen ...
CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...
Everyday physical complaints like cracked lips, dandruff, dry skin, restless legs, and mouth ulcers can signal underlying ...
Detailed price information for Solid Biosciences Inc (SLDB-Q) from The Globe and Mail including charting and trades.
After water crisis in Madhya Pradesh's Indore, groundwater samples from several parts of Bhopal have tested positive for E.
Hutchmed Ltd. plans to file a second NDA in China for sovleplenib, a novel spleen tyrosine kinase inhibitor, based on positive phase II/III findings in warm antibody autoimmune hemolytic anemia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results